BioLineRx Ltd.
BLRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10 | $4 | $11 | $13 |
| Short-Term Investments | $9 | $39 | $40 | $44 |
| Receivables | $4 | $1 | $1 | $0 |
| Inventory | $3 | $2 | $0 | $0 |
| Other Curr. Assets | $1 | $2 | $0 | $0 |
| Total Curr. Assets | $27 | $47 | $52 | $57 |
| Property Plant & Equip (Net) | $1 | $2 | $2 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $10 | $15 | $22 | $22 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $12 | $17 | $24 | $24 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $39 | $64 | $76 | $81 |
| Liabilities | – | – | – | – |
| Payables | $6 | $11 | $7 | $6 |
| Short-Term Debt | $5 | $4 | $2 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $13 | $0 | $0 |
| Other Curr. Liab. | $5 | $15 | $2 | $1 |
| Total Curr. Liab. | $15 | $43 | $11 | $10 |
| LT Debt | $10 | $8 | $10 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $12 | $5 | $2 |
| Total NC Liab. | $10 | $20 | $15 | $4 |
| Other Liabilities | $0 | -$12 | $0 | $0 |
| Cap. Leases | $2 | $2 | $2 | $2 |
| Total Liabilities | $25 | $51 | $26 | $13 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $38 | $31 | $27 | $21 |
| Retained Earnings | -$400 | -$391 | -$330 | -$305 |
| AOCI | $16 | $17 | $15 | $13 |
| Other Equity | $359 | $355 | $339 | $339 |
| Total Equity | $13 | $13 | $51 | $68 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $39 | $64 | $76 | $81 |
| Net Debt | $5 | $7 | $2 | -$8 |